Zhuochao Zhang
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Retraction Note: PTBP3 splicing factor promotes hepatocellular carcinoma by destroying the splicing balance of NEAT1 and pre-miR-612.
Journal: Oncogene
Published: March 08, 2023
High MRPS23 expression contributes to hepatocellular carcinoma proliferation and indicates poor survival outcomes.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: July 18, 2017
The mTOR inhibition in concurrence with ERK1/2 activation is involved in excessive autophagy induced by glycyrrhizin in hepatocellular carcinoma.
Journal: Cancer medicine
Published: July 09, 2016
Antigen-specific T cell response from dendritic cell vaccination using side population cell-associated antigens targets hepatocellular carcinoma.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: November 23, 2015
Downregulation of lncRNA-ATB correlates with clinical progression and unfavorable prognosis in pancreatic cancer.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: August 28, 2015
RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: August 19, 2015
Microarray expression profile of circular RNAs in human pancreatic ductal adenocarcinoma.
Journal: Genomics data
Published: July 07, 2015
Pig BMSCs Transfected with Human TFPI Combat Species Incompatibility and Regulate the Human TF Pathway in Vitro and in a Rodent Model.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: March 04, 2015
Last Updated: 09/26/2026